AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21863617 — intervention group
Group type: COMPARATOR
Intervention: Preoperative hydration with 20 ml/kg of Ringer solution
Number of subjects: 40
Study 21863617 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of ephedrine
Number of subjects: 40
Study 21863617 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 19391528 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion combined with intermittent urethral catheterization
Number of subjects: 76
Study 19391528 — intervention group
Group type: COMPARATOR
Intervention: Routine intermittent urethral catheterization
Number of subjects: 76
Study 17187936 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report of abstinence from alcohol
Number of subjects: 253
Study 17187936 — intervention group
Group type: COMPARATOR
Intervention: Partner reports of women's abstinence from alcohol
Number of subjects: 253
Study 17187936 — intervention group
Group type: COMPARATOR
Intervention: Post-partum agreement between dyads
Number of subjects: 253
Study 15489205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention assessed through a 5-day dietary record (DR) and food-frequency questionnaire (FFQ)
Number of subjects: 0
Study 15489205 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention assessed through FFQ
Number of subjects: 0
Study 11564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (mean daily dose 13 +/- 1.5 mg/kg)
Number of subjects: 300
Study 11564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (mean daily dose 3 +/- 0.4 mg/kg)
Number of subjects: 300
Study 11564387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 11564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 300
Study 11564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 300
Study 11564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone and Sotalol
Number of subjects: 300
Study 9692539 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm deformity index
Number of subjects: 94
Study 9692539 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple anomalies index
Number of subjects: 94
Study 8186281 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 32
Study 2491468 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine b.d.
Number of subjects: 336
Study 2491468 — intervention group
Group type: COMPARATOR
Intervention: 300 mg ranitidine nocte
Number of subjects: 336
Study 2491468 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 336
Study 955495 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid
Number of subjects: 66
Study 955495 — intervention group
Group type: COMPARATOR
Intervention: Cholic acid or placebo
Number of subjects: 66
Study 31412092 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived work-induced lumbar exertion
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-site pain
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-related fear-avoidance beliefs (FAB-W)
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar exertion
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: FAB-W
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical performance in figure-of-eight running
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified push-ups
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 219
Study 28795185 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery after work
Number of subjects: 219
Study 25747197 — intervention group
Group type: EXPERIMENTAL
Intervention: Trebananib 10 mg/kg once weekly plus paclitaxel and bevacizumab (Arm A)
Number of subjects: 228
Study 25747197 — intervention group
Group type: EXPERIMENTAL
Intervention: Trebananib 3 mg/kg once weekly plus paclitaxel and bevacizumab (Arm B)
Number of subjects: 228
Study 25747197 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel and bevacizumab (Arm C)
Number of subjects: 228
Study 25747197 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly plus paclitaxel (Arm D)
Number of subjects: 228
Study 25747197 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly (Arm D) with high exposure
Number of subjects: 228
Study 25747197 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label trebananib 10 mg/kg once weekly (Arm D) with low exposure
Number of subjects: 228
Study 23167499 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Tai Chi exercises
Number of subjects: 152
Study 23167499 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy exercises
Number of subjects: 152
Study 23159551 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD‐CRT
Number of subjects: 1798
Study 23159551 — intervention group
Group type: COMPARATOR
Intervention: ICD only
Number of subjects: 1798
Study 20112576 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbs promoting blood circulation and removing blood stasis (Caesalpinia Sappan 10 g, Ligusticum Chuanxiong 6 g, Frankincense 6 g, Angelica 10 g, Safflower 6 g, Myrrh 6 g, Ground Beetle 10 g, Araliaceae 3 g, Radix Paeoniae Rubra 10 g, Pericarpium Citri Reticulatae 5 g, Lawn Pennywort Herb 15 g, Manis Pentadactyla 10 g, Corydalis Yanhusuo 10 g, Rhizoma Drynariae 15 g) taken orally for 10 days, and external application of traditional medicine for fuming and washing limbs twice daily.
Number of subjects: 58
Study 20112576 — intervention group
Group type: COMPARATOR
Intervention: Placebo of the same color for oral use and external application, with the same delivery times and therapy duration as the treatment group.
Number of subjects: 58
Study 20112576 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbs promoting blood circulation and removing blood stasis (same as above).
Number of subjects: 58
Study 20112576 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same as above).
Number of subjects: 58
Study 17225034 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling in the home setting
Number of subjects: 36
Study 17225034 — intervention group
Group type: COMPARATOR
Intervention: Outpatient rehabilitation
Number of subjects: 36
Study 15127282 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pain education (10‐15 min per day for 5 days)
Number of subjects: 30
Study 15127282 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 30
Study 11772964 — intervention group
Group type: EXPERIMENTAL
Intervention: FOBT screening (group 1)
Number of subjects: 3548
Study 11772964 — intervention group
Group type: COMPARATOR
Intervention: Refusers (group 2)
Number of subjects: 3548
Study 9851958 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagal maneuvers
Number of subjects: 133
Study 9851958 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 133
Study 7986160 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol hydrochloride (nonselective beta 1‐ and beta 2‐blocker)
Number of subjects: 16
Study 7986160 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol tartrate (selective beta 1‐blocker)
Number of subjects: 16
Study 7986160 — intervention group
Group type: COMPARATOR
Intervention: Control (no beta-blocker)
Number of subjects: 16
Study 2623708 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive care program in dental practice, details on dosage and duration not specified.
Number of subjects: 0
Study 1184719 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.15 mg iv)
Number of subjects: 6
Study 1184719 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 6
Study 1184719 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (selective dopamine receptor agonist)
Number of subjects: 6
Study 31609315 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive-oil-based three-chamber bags (3CBs)
Number of subjects: 458
Study 31609315 — intervention group
Group type: COMPARATOR
Intervention: Soybean-oil-based compounded bags (CoBs)
Number of subjects: 458
Study 29358855 — intervention group
Group type: COMPARATOR
Intervention: 30 min ischemia followed by 30 min reperfusion (30I30R)
Number of subjects: 1
Study 29358855 — intervention group
Group type: COMPARATOR
Intervention: 30 min ischemia followed by 120 min reperfusion (30I120R)
Number of subjects: 1
Study 29358855 — intervention group
Group type: COMPARATOR
Intervention: 30 min ischemia (30I)
Number of subjects: 1
Study 29358855 — intervention group
Group type: COMPARATOR
Intervention: Citrulline concentrations
Number of subjects: 1
Study 26165582 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Self-Management Program
Number of subjects: 405
Study 26165582 — intervention group
Group type: EXPERIMENTAL
Intervention: General Self-Management Program
Number of subjects: 405
Study 26165582 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 405
Study 24221463 — intervention group
Group type: EXPERIMENTAL
Intervention: 33‐gauge injection device without a speculum
Number of subjects: 70
Study 24221463 — intervention group
Group type: COMPARATOR
Intervention: 30‐gauge needle using a speculum
Number of subjects: 70
Study 21485071 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese drugs for supplementing qi-blood and nourishing Gan-Shen (Cuhuangti Granule and Jinghou Zengzhi Granule)
Number of subjects: 86
Study 21485071 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard regimen for promoting ovulation)
Number of subjects: 86
Study 19430945 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise bout (65% V(O)(2max); 600 kcal expended)
Number of subjects: 18
Study 19430945 — intervention group
Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 18
Study 16570008 — intervention group
Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 34
Study 16570008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir and immunoglobulin (IG)
Number of subjects: 34
Study 16570008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir and IG
Number of subjects: 34
Study 12742279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 20 mg twice daily
Number of subjects: 254
Study 12742279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 40 mg twice daily
Number of subjects: 254
Study 12742279 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 60 mg twice daily
Number of subjects: 254
Study 12742279 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 254
Study 10858869 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiodoron (herbal extract composition)
Number of subjects: 100
Study 10858869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9222232 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-wavelength sensitivity measurement
Number of subjects: 172
Study 8477130 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 123
Study 8477130 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam
Number of subjects: 123
Study 8477130 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 123
Study 2947105 — intervention group
Group type: EXPERIMENTAL
Intervention: Tentative protocol combining multiple individual assessments with validated scales and tests.
Number of subjects: 0
Study 2947105 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 29428831 — intervention group
Group type: EXPERIMENTAL
Intervention: LOP technique
Number of subjects: 160
Study 29428831 — intervention group
Group type: COMPARATOR
Intervention: Standard pneumatic ischemia technique
Number of subjects: 160
Study 26699670 — intervention group
Group type: EXPERIMENTAL
Intervention: PEAS-Diet (interview-administered version)
Number of subjects: 361
Study 26699670 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 361
Study 24885132 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical antimicrobial prophylaxis administered in the anesthesia room (75 to 30 minutes before incision)
Number of subjects: 5000
Study 24885132 — intervention group
Group type: COMPARATOR
Intervention: Surgical antimicrobial prophylaxis administered in the operating room (less than 30 minutes before incision)
Number of subjects: 5000
Study 22457015 — intervention group
Group type: EXPERIMENTAL
Intervention: Clevidipine (2.0 mg/h, titrated to target dose up to 16.0 mg/h)
Number of subjects: 61
Study 22457015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 19673922 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading (overdenture connected 1 week after surgery)
Number of subjects: 26
Study 19673922 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (overdenture connected 3 months after surgery)
Number of subjects: 26
Study 17431817 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA supplementation (AA 0.46 wt%, DHA 0.27 wt%)
Number of subjects: 21
Study 17431817 — intervention group
Group type: COMPARATOR
Intervention: Phenylalanine-free amino acid supplements without LCPUFA
Number of subjects: 21
Study 15608499 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-tocopherol-enriched rinse-off product (test product, TP)
Number of subjects: 13
Study 15608499 — intervention group
Group type: COMPARATOR
Intervention: alpha-tocopherol-free vehicle control (control product, CP)
Number of subjects: 13
Study 12366781 — intervention group
Group type: EXPERIMENTAL
Intervention: CA genotype at position -607 in sarcoidosis patients
Number of subjects: 119
Study 12366781 — intervention group
Group type: EXPERIMENTAL
Intervention: C allele at position -607 in sarcoidosis patients
Number of subjects: 119
Study 12366781 — intervention group
Group type: COMPARATOR
Intervention: Genotype distribution at position -137
Number of subjects: 119
Study 9895042 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 154
Study 9895042 — intervention group
Group type: COMPARATOR
Intervention: No endoscopy
Number of subjects: 154
Study 9895042 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy and No endoscopy
Number of subjects: 154
Study 7625106 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant DNA yeast-derived HB vaccine booster dose
Number of subjects: 0
Study 7625106 — intervention group
Group type: EXPERIMENTAL
Intervention: Four doses of primary immunization
Number of subjects: 0
Study 7625106 — intervention group
Group type: COMPARATOR
Intervention: Three doses of primary immunization
Number of subjects: 0
Study 7625106 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary immunization (overall)
Number of subjects: 0
Study 7625106 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related antibody levels
Number of subjects: 0
Study 7625106 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose
Number of subjects: 0
Study 2204779 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent advances in management of diabetic retinal vascular disease
Number of subjects: 0
Study 357071 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg 3 times a day
Number of subjects: 11
Study 357071 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg 3 times a day
Number of subjects: 11
Study 357071 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 30 mg daily
Number of subjects: 11
Study 357071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31756389 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 1771
Study 31756389 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 1771
Study 31756389 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure increment by 2 classes
Number of subjects: 1771
Study 31756389 — intervention group
Group type: EXPERIMENTAL
Intervention: AF presence during follow-up
Number of subjects: 1771
Study 31756389 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular rate >80 beats/min
Number of subjects: 1771
Study 31756389 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher frequency of recorded AF in rhythm arm
Number of subjects: 1771
Study 30659286 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic therapy
Number of subjects: 31
Study 30659286 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy
Number of subjects: 31
Study 30659286 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 31
Study 27590629 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention (walking, resistance training, and flexibility exercises)
Number of subjects: 1476
Study 27590629 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 1476
Study 27590629 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1476
Study 26190153 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a very high temperature
Number of subjects: 15
Study 26190153 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a low temperature
Number of subjects: 15
Study 26190153 — intervention group
Group type: COMPARATOR
Intervention: Durum wheat pasta dried at a low temperature (control)
Number of subjects: 15
Study 26190153 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasta enriched with 35% faba bean dried at a high temperature
Number of subjects: 15
Study 24851582 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise program applying the Theory of Planned Behavior
Number of subjects: 68
Study 24851582 — intervention group
Group type: COMPARATOR
Intervention: Health information and booklet practice
Number of subjects: 68
Study 21285450 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild CKD (prepregnancy Cr < 125 µmol/Cr > 100 µmol at booking; n = 22)
Number of subjects: 66
Study 21285450 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/severe CKD (prepregnancy creatinine > 125 µmol; n = 14)
Number of subjects: 66
Study 21285450 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinuria (≥2+) with concomitant risk of PE
Number of subjects: 66
Study 19573478 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 165
Study 19573478 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 165
Study 19573478 — intervention group
Group type: COMPARATOR
Intervention: Cognitive abilities
Number of subjects: 165
Study 15818296 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 192
Study 12441754 — intervention group
Group type: EXPERIMENTAL
Intervention: NPPV
Number of subjects: 6
Study 12441754 — intervention group
Group type: COMPARATOR
Intervention: 10 cm H2O CPAP
Number of subjects: 6
Study 12441754 — intervention group
Group type: COMPARATOR
Intervention: 5 cm H2O CPAP
Number of subjects: 6
Study 10527972 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional in-vitro fertilization (IVF)
Number of subjects: 56
Study 10527972 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 56
Study 10527972 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as the comparison between IVF and ICSI)
Number of subjects: 56
Study 9395631 — intervention group
Group type: EXPERIMENTAL
Intervention: Sambucol (SAM)
Number of subjects: 0
Study 9395631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1953974 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-powder gruel (RPG)
Number of subjects: 70
Study 1953974 — intervention group
Group type: COMPARATOR
Intervention: Oral rehydration salts (ORS)
Number of subjects: 70
Study 7468619 — intervention group
Group type: EXPERIMENTAL
Intervention: diet plus tolazamide
Number of subjects: 25
Study 7468619 — intervention group
Group type: COMPARATOR
Intervention: diet plus placebo
Number of subjects: 25
Study 31264950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous contrast agent administration (CT angiography)
Number of subjects: 320
Study 31264950 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial contrast agent administration (catheterization)
Number of subjects: 320
Study 31264950 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcontrast AKI
Number of subjects: 320
Study 29101842 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial Direct Current Stimulation (tDCS) applied to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study 29101842 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 29101842 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0
Study 24754705 — intervention group
Group type: EXPERIMENTAL
Intervention: Competitive swim macrocycle (16 weeks)
Number of subjects: 49
Study 24754705 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-swimmers)
Number of subjects: 49
Study 23831913 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg Q10 daily for 12 weeks
Number of subjects: 64
Study 23831913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 21183326 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium 200 μg
Number of subjects: 181
Study 21183326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 21246788 — intervention group
Group type: EXPERIMENTAL
Intervention: Propiverin 30 mg daily
Number of subjects: 28
Study 21246788 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propiverin 30 mg daily and tamsulosin 0.4 mg daily
Number of subjects: 28
Study 17576207 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral delayed release granules
Number of subjects: 24
Study 17576207 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL rectal foam
Number of subjects: 24
Study 17576207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal delivery of 5‐ASA
Number of subjects: 24